Decreased Whole Body Endogenous Nitric Oxide Production in Patients with Primary Pulmonary Hypertension
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Impaired pulmonary release of nitric oxide (NO) is one of the characteristic phenotypic changes of vascular cells in pulmonary hypertension. The aim of this study was to determine nitric oxide synthase (NOS)-dependent whole body NO production in patients with primary pulmonary hypertension. NOS-dependent whole body NO production was assessed by giving an intravenous infusion of L-[15 N]2-arginine (50 µmol/min for 30 min) and measuring isotopic urinary enrichment of 15 N-nitrite and 15 N-nitrate. Four female patients with no signs of infection were recruited and compared with 6 age-matched control subjects. Mean 12-hour excretion of 15 N-nitrite and 15 N-nitrate in the total urine over 36 h was smaller in patients than in control subjects (57.2 ± 27.6 vs. 229.1 ± 65.2 nmol/mmol creatinine, p< 0.01, Mann-Whitney U test, respectively). Neither mean 12-hour excretion of 14 N-nitrite and 14 N-nitrate (51.6 ± 10.0 vs. 72.4 ± 10.0 µmol/mmol creatinine, p = 0.3) nor glomerular filtration rates (84.5 ± 15.8 vs. 129.7 ± 16.0 ml/min, p = 0.1) were different between patients and control subjects. Our results suggest that either basal NOS-dependent whole body NO production is impaired or excess NO metabolism occurs in patients with primary pulmonary hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807 · cited 1×
“], formation of nitrotyrosine or other nitrated proteins might shunt NO consumption away from terminal oxidation to nitrite, which acts as source of NO in the vasculature [ , ,”
BackgroundKANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., & ERZURUM, S. C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9802066 · Cited by 228 · cited 1×
“], almost all studies to date have used exhaled breath NO and biochemical products of NO to infer the involvement of NOS in pulmonary hypertension [ ,”
BackgroundCirculating nitrite anions are a directly acting vasodilator and are donors for nitric oxide
DEMONCHEAUX, E. A. G., HIGENBOTTAM, T. W., FOSTER, P. J., BORLAND, C. D. R., SMITH, A. P. L., MARRIOTT, H. M., BEE, D., AKAMINE, S., & DAVIES, M. B. (2002) · Clinical Science · doi:10.1042/cs1020077 · Cited by 48 · cited 1×
“formation of nitrotyrosine or other nitrated proteins might shunt NO consumption away from terminal oxidation to nitrite, which acts as source of NO in the vasculature [”
BackgroundSelf-citation
Cited by
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186
Siervo, M., Stephan, B. C. M., Feelisch, M., & Bluck, L. J. C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.032 · Cited by 52
“Medical conditions such as primary pulmonary hypertension [51,61], nonseptic malnutrition, or nonseptic acute diseases [63] were associated with noninflammatory catabolic states, which determined a decline in NO synthesis via a reduction in arginine bioavailability and impairment of endothelial function.”
BackgroundSafety of sapropterin dihydrochloride (6r–bh4) in patients with pulmonary hypertension
Robbins, I. M., Hemnes, A. R., Simon Gibbs, J., Christman, B. W., Howard, L., Meehan, S., Cabrita, I., Gonzalez, R., Oyler, T., Zhao, L., et al. (2011) · Experimental Lung Research · doi:10.3109/01902148.2010.512972 · Cited by 47
Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Renal nitrate clearance in chronic kidney disease
Williams, J. K., Smallwood, M. J., Benjamin, N., D'Souza, R. J., Shore, A. C., Winyard, P. G., & Gilchrist, M. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.01.011 · Cited by 19
“A small case control study of patients with primary pulmonary hypertension from Demonocheaux et al [28], who used an isotope enrichment technique, demonstrated a substantial reduction in NO synthesis but unaltered urinary nitrate excretion.”
Background
Metadata
- Authors
- Demoncheaux, E. A. G., Higenbottam, T. W., Kiely, D. G., Wong, J.-M., Wharton, S., Varcoe, R., Siddons, T., Spivey, A. C., Hall, K., & Gize, A. P.
- Venue
- Journal of Vascular Research
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 42
- Issue
- 2
- Pages
- 133-136
- ISSN
- 1018-1172 (ISSN-L)
- 1423-0135
- OpenAlex
- W2074507891
- Cited by
- 48
- References
- 3
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.